Grupo de Investigación en Fisiopatología Cardiovascular
CTS237
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital General Universitario Gregorio Marañón (20)
2024
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
-
Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study
eClinicalMedicine, Vol. 73
-
The prognostic value of blood cellular indices in pulmonary embolism
American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711
2023
-
COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
2022
2021
-
Case-control analysis of the impact of anemia on quality of life in patients with cancer: A Qca study analysis
Cancers, Vol. 13, Núm. 11
-
Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416
2020
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
-
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world
Journal of Hepatology, Vol. 71, Núm. 5, pp. 876-888
2018
-
Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis
PLoS ONE, Vol. 13, Núm. 7
-
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437
2017
-
Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis
Thrombosis and Haemostasis, Vol. 117, Núm. 6, pp. 1192-1198
2016
-
Hepatic safety of rilpivirine/emtricitabine/tenofovir disoproxil fumarate fixed-dose single-tablet regimen in HIV-infected patients with active hepatitis C virus infection: The hepatic study
PLoS ONE, Vol. 11, Núm. 5
-
Quality indicators to assure and improve cancer care in Spain using the delphi technique
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558
2015
-
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs
American Journal of Medicine, Vol. 128, Núm. 1, pp. 90.e9-90.e15
-
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry
Thrombosis Journal, Vol. 13, Núm. 1
2009
-
Prevalencia de enfermedad arterial periférica asintomática en pacientes con ictus isquémico no cardioembólico
Neurologia, Vol. 24, Núm. 6, pp. 366-372